Page last updated: 2024-09-03

blonanserin and Psychotic Disorders

blonanserin has been researched along with Psychotic Disorders in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Endo, M; Fujita, K; Fukami, G; Hashimoto, T; Hata, T; Hattori, N; Hosoda, Y; Imamura, Y; Inoue, M; Ishikawa, M; Iyo, M; Kanahara, N; Kawasaki, Y; Kimura, A; Murakami, T; Niitsu, T; Nishimoto, M; Oda, Y; Ogawa, K; Sato, T; Seki, R; Shiina, A; Suzuki, M; Takase, N; Yoshida, T1
Suzuki, M; Takahashi, S; Uchiyama, M1
Bavle, A1

Trials

2 trial(s) available for blonanserin and Psychotic Disorders

ArticleYear
A randomized-controlled trial of blonanserin and olanzapine as adjunct to antipsychotics in the treatment of patients with schizophrenia and dopamine supersensitivity psychosis: The ROADS study.
    Asian journal of psychiatry, 2020, Volume: 53

    Topics: Antipsychotic Agents; Benzodiazepines; Dopamine; Humans; Olanzapine; Piperazines; Piperidines; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Treatment Outcome

2020
One-year follow-up study of psychotic patients treated with blonanserin: a case series.
    Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists, 2013, Volume: 5, Issue:3

    Topics: Adult; Antipsychotic Agents; Female; Follow-Up Studies; Humans; Piperazines; Piperidines; Prolactin; Psychotic Disorders; Quality of Life; Schizophrenia

2013

Other Studies

2 other study(ies) available for blonanserin and Psychotic Disorders

ArticleYear
A case report of blonanserin-induced hyponatremia.
    The Journal of neuropsychiatry and clinical neurosciences, 2014,Summer, Volume: 26, Issue:3

    Topics: Antidepressive Agents; Depressive Disorder, Major; Female; Humans; Hyponatremia; Middle Aged; Piperazines; Piperidines; Psychotic Disorders

2014
Blonanserin. AD 5423.
    Drugs in R&D, 2002, Volume: 3, Issue:6

    Topics: Animals; Antipsychotic Agents; Drug Tolerance; Humans; Mice; Piperazines; Piperidines; Psychotic Disorders

2002